Reperfusion. Primary percutaneous coronary intervention with first medical contact to wire passage within 120 minutes.
If this is not possible, give fibrinolysis within 10 minutes of diagnosis with tenecteplase, dosed by weight: 30 mg under 60 kg, 35 mg for 60 to under 70 kg, 40 mg for 70 to under 80 kg, 45 mg for 80 to under 90 kg, 50 mg for 90 kg or over. Use half dose from age 75.
Alteplase accelerated regimen: 15 mg bolus, then 0.75 mg/kg over 30 minutes (maximum 50 mg), then 0.5 mg/kg over 60 minutes (maximum 35 mg).
Absolute contraindications: previous intracranial haemorrhage, ischaemic stroke in 6 months, central nervous system tumour or vascular malformation, major trauma or surgery in 1 month, gastrointestinal bleeding in 1 month, known bleeding disorder, aortic dissection, and non-compressible puncture in 24 hours.
Rescue angioplasty if ST resolution is under 50% at 60 to 90 minutes. Routine angiography 2 to 24 hours after successful lysis. Judge ST resolution on posterior leads or the anterior ST depression.
Antithrombotic therapy.
- Aspirin 150 to 300 mg orally loading dose, then 75 to 100 mg daily.
- Ticagrelor 180 mg orally loading dose, then 90 mg twice daily for 12 months.
- Alternatively prasugrel 60 mg loading dose, then 10 mg daily (5 mg when weight is under 60 kg or age is 75 or over).
- Alternatively clopidogrel 600 mg loading dose, then 75 mg daily. With fibrinolysis, clopidogrel 300 mg (or 75 mg from age 75), then 75 mg daily.
- Unfractionated heparin 70 to 100 units/kg intravenous bolus in percutaneous coronary intervention (60 units/kg with a glycoprotein IIb/IIIa inhibitor).
- With fibrinolysis, give enoxaparin 30 mg intravenous bolus then 1 mg/kg subcutaneously every 12 hours (maximum 100 mg for the first two doses). Give it once daily when creatinine clearance is under 30 mL/min. From age 75, use 0.75 mg/kg every 12 hours without bolus.
Supportive treatment.
- Oxygen only for SpO2 under 90%.
- Glyceryl trinitrate 400 to 800 microgram sublingually, then 10 to 200 microgram/min intravenously for pain. Avoid it with systolic pressure under 90 mmHg or right ventricular involvement.
- Intravenous opioid for pain in small titrated doses (fentanyl 25 to 50 microgram), since opioids delay absorption of oral antiplatelets.
- Metoprolol 25 to 50 mg orally twice daily within 24 hours when there is no heart failure, hypotension or block.
- Bradycardia and block (right coronary lesions): atropine 0.5 mg intravenously, repeated to 3 mg, then temporary pacing if needed.
- Mitral regurgitation from papillary muscle rupture: urgent surgery with afterload reduction and balloon counterpulsation as a bridge.
Secondary prevention.
- Atorvastatin 40 to 80 mg once daily (LDL cholesterol under 1.4 mmol/L).
- Ramipril 2.5 mg daily titrated to 10 mg.
- Metoprolol succinate 25 to 200 mg daily.
- Eplerenone 25 to 50 mg daily when ejection fraction is 40% or under with heart failure or diabetes (potassium under 5.0 mmol/L).
- Omeprazole 20 mg daily while on dual antiplatelet therapy.
- Smoking cessation and cardiac rehabilitation.
Monitoring. Continuous ECG for 24 to 48 hours, troponin at presentation and 3 to 6 hours later, echocardiography at 24 to 48 hours, creatinine and potassium at 1 to 2 weeks after starting ACE inhibitor or eplerenone, lipids at 4 to 12 weeks.
Referral and escalation. Activate the catheter laboratory on the basis of the posterior lead ECG. Urgent surgical referral for new mitral regurgitation, heart failure or shock.
Special groups.
- Older adults: use half dose tenecteplase from age 75 and enoxaparin 0.75 mg/kg subcutaneously every 12 hours without a bolus; watch bleeding.
- Kidney impairment: give enoxaparin once daily when creatinine clearance is under 30 mL/min and avoid contrast excess.
- Pregnancy: spontaneous coronary artery dissection is the usual cause; avoid fibrinolysis where possible.
- Region specific: where angiography is delayed, record posterior leads early to avoid missing the diagnosis.